Douglas Miehm
Stock Analyst at RBC Capital
(0)
# 3890
Out of 5,218 analysts
44
Total ratings
53.57%
Success rate
-1.37%
Average return
Main Sectors:
| Name | Action | Price Target | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
Ligand Pharmaceutica... | Maintains: Outperform | 130 140 | 116.97 | 19.69% | 4 | Nov 12, 2024 | |
Bausch Health Compan... | Maintains: Sector Perform | 10 11 | 7.78 | 41.39% | 18 | Nov 1, 2024 | |
Bausch & Lomb | Maintains: Outperform | 20 23 | 18.59 | 23.72% | 10 | Oct 22, 2024 | |
Aurinia Pharmaceutic... | Maintains: Outperform | 13 8 | 9.37 | -14.62% | 9 | Feb 16, 2024 | |
CRH Medical | Downgrades: Sector Perform | n/a | n/a | n/a | 1 | Feb 9, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Sector Perform | n/a | n/a | n/a | 1 | Jul 13, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | n/a | n/a | n/a | 1 | Jul 20, 2016 |